Testicular function of actively immunized male rats with LH releasing hormone (LHRH): A possible role of prolactin on regulation of spermatogenesis

K. Shiota, M. Takahashi, Y. Suzuki

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The effect of testosterone propionate (TP) on the recovery of spermatogenesis was compared in 3 types of experimentally induced gonadotropin-deficient rats; 1. hypophysectomized rats, 2. rats actively immunized to LHRH and 3. hypophysectomized and immunized rats bearing a pituitary isograft. In order to immunize animals to LHRH, deamidated LHRH conjungated with BSA (LHRH-BSA) was injected intradermaly to male rats 4 times at 2 week intervals and additional booster injections contained once a month. Anti-LHRH titer was the highest on the 12th week and the titer remained at a relatively high levels thereafter. A remarkable decrease in testicular weight and testosterone production was achieved in 10 weeks associated with a drop in serum LH and FSH levels. In long term immunized rat (LIM rats) which had been immunized for more than 3 months, testicular atrophy advanced to a similar extent to that in long term hypophysectomized rats (HX rats). The administration of TP (1 mg/day) sc for 30 days restored spermatogenesis in LIM rats. The simultaneous administration of anti-LH and -FSH sera in addition to TP did not affect the restoration of spermatogenesis in LIM rats. The same TP treatment in HX rats, however, failed to restore spermatogenesis. Spermatogenesis was reinitiated after TP treatment if immunized-hypophysectomized rats received a pituitary isograft. Though the serum PRL level in LIM rats was one fifth of that in normal rats, a 2.5-fold rise in the PRL level was observed after TP treatment. These results suggest that PRL is involved in the process of spermatogenesis.

Original languageEnglish
Pages (from-to)521-534
Number of pages14
JournalEndocrinologia Japonica
Volume28
Issue number4
Publication statusPublished - 1981
Externally publishedYes

Fingerprint

Spermatogenesis
Gonadotropin-Releasing Hormone
Prolactin
Testosterone Propionate
Isografts
Serum
Gonadotropins
Atrophy
Testosterone
Therapeutics

ASJC Scopus subject areas

  • Endocrinology

Cite this

Testicular function of actively immunized male rats with LH releasing hormone (LHRH) : A possible role of prolactin on regulation of spermatogenesis. / Shiota, K.; Takahashi, M.; Suzuki, Y.

In: Endocrinologia Japonica, Vol. 28, No. 4, 1981, p. 521-534.

Research output: Contribution to journalArticle

@article{25003b8b8271495b89dc324f9da7da21,
title = "Testicular function of actively immunized male rats with LH releasing hormone (LHRH): A possible role of prolactin on regulation of spermatogenesis",
abstract = "The effect of testosterone propionate (TP) on the recovery of spermatogenesis was compared in 3 types of experimentally induced gonadotropin-deficient rats; 1. hypophysectomized rats, 2. rats actively immunized to LHRH and 3. hypophysectomized and immunized rats bearing a pituitary isograft. In order to immunize animals to LHRH, deamidated LHRH conjungated with BSA (LHRH-BSA) was injected intradermaly to male rats 4 times at 2 week intervals and additional booster injections contained once a month. Anti-LHRH titer was the highest on the 12th week and the titer remained at a relatively high levels thereafter. A remarkable decrease in testicular weight and testosterone production was achieved in 10 weeks associated with a drop in serum LH and FSH levels. In long term immunized rat (LIM rats) which had been immunized for more than 3 months, testicular atrophy advanced to a similar extent to that in long term hypophysectomized rats (HX rats). The administration of TP (1 mg/day) sc for 30 days restored spermatogenesis in LIM rats. The simultaneous administration of anti-LH and -FSH sera in addition to TP did not affect the restoration of spermatogenesis in LIM rats. The same TP treatment in HX rats, however, failed to restore spermatogenesis. Spermatogenesis was reinitiated after TP treatment if immunized-hypophysectomized rats received a pituitary isograft. Though the serum PRL level in LIM rats was one fifth of that in normal rats, a 2.5-fold rise in the PRL level was observed after TP treatment. These results suggest that PRL is involved in the process of spermatogenesis.",
author = "K. Shiota and M. Takahashi and Y. Suzuki",
year = "1981",
language = "English",
volume = "28",
pages = "521--534",
journal = "Endocrine Journal",
issn = "0918-8959",
publisher = "Japan Endocrine Society",
number = "4",

}

TY - JOUR

T1 - Testicular function of actively immunized male rats with LH releasing hormone (LHRH)

T2 - A possible role of prolactin on regulation of spermatogenesis

AU - Shiota, K.

AU - Takahashi, M.

AU - Suzuki, Y.

PY - 1981

Y1 - 1981

N2 - The effect of testosterone propionate (TP) on the recovery of spermatogenesis was compared in 3 types of experimentally induced gonadotropin-deficient rats; 1. hypophysectomized rats, 2. rats actively immunized to LHRH and 3. hypophysectomized and immunized rats bearing a pituitary isograft. In order to immunize animals to LHRH, deamidated LHRH conjungated with BSA (LHRH-BSA) was injected intradermaly to male rats 4 times at 2 week intervals and additional booster injections contained once a month. Anti-LHRH titer was the highest on the 12th week and the titer remained at a relatively high levels thereafter. A remarkable decrease in testicular weight and testosterone production was achieved in 10 weeks associated with a drop in serum LH and FSH levels. In long term immunized rat (LIM rats) which had been immunized for more than 3 months, testicular atrophy advanced to a similar extent to that in long term hypophysectomized rats (HX rats). The administration of TP (1 mg/day) sc for 30 days restored spermatogenesis in LIM rats. The simultaneous administration of anti-LH and -FSH sera in addition to TP did not affect the restoration of spermatogenesis in LIM rats. The same TP treatment in HX rats, however, failed to restore spermatogenesis. Spermatogenesis was reinitiated after TP treatment if immunized-hypophysectomized rats received a pituitary isograft. Though the serum PRL level in LIM rats was one fifth of that in normal rats, a 2.5-fold rise in the PRL level was observed after TP treatment. These results suggest that PRL is involved in the process of spermatogenesis.

AB - The effect of testosterone propionate (TP) on the recovery of spermatogenesis was compared in 3 types of experimentally induced gonadotropin-deficient rats; 1. hypophysectomized rats, 2. rats actively immunized to LHRH and 3. hypophysectomized and immunized rats bearing a pituitary isograft. In order to immunize animals to LHRH, deamidated LHRH conjungated with BSA (LHRH-BSA) was injected intradermaly to male rats 4 times at 2 week intervals and additional booster injections contained once a month. Anti-LHRH titer was the highest on the 12th week and the titer remained at a relatively high levels thereafter. A remarkable decrease in testicular weight and testosterone production was achieved in 10 weeks associated with a drop in serum LH and FSH levels. In long term immunized rat (LIM rats) which had been immunized for more than 3 months, testicular atrophy advanced to a similar extent to that in long term hypophysectomized rats (HX rats). The administration of TP (1 mg/day) sc for 30 days restored spermatogenesis in LIM rats. The simultaneous administration of anti-LH and -FSH sera in addition to TP did not affect the restoration of spermatogenesis in LIM rats. The same TP treatment in HX rats, however, failed to restore spermatogenesis. Spermatogenesis was reinitiated after TP treatment if immunized-hypophysectomized rats received a pituitary isograft. Though the serum PRL level in LIM rats was one fifth of that in normal rats, a 2.5-fold rise in the PRL level was observed after TP treatment. These results suggest that PRL is involved in the process of spermatogenesis.

UR - http://www.scopus.com/inward/record.url?scp=0019758656&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019758656&partnerID=8YFLogxK

M3 - Article

C2 - 6820774

AN - SCOPUS:0019758656

VL - 28

SP - 521

EP - 534

JO - Endocrine Journal

JF - Endocrine Journal

SN - 0918-8959

IS - 4

ER -